Asul

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Asul

Property Description
Active ingredient Salbutamol (Albuterol)
Primary Form Pressurized metered dose inhaler
Pharmacological class Selective beta2-adrenergic Agonist (SABA)
Common purpose Fast relief of acute airway constriction
Origin Synthetic

Asul is a specific pharmaceutical preparation containing the active substance Salbutamol, which is recognized globally as its International Nonproprietary Name (INN) and is widely known as Albuterol in the United States. This single-entity product is a synthetic compound typically formulated as Salbutamol sulfate and is primarily positioned as a fast-acting rescue inhaler. The medication is most commonly administered via the pulmonary route using a pressurized metered dose inhaler or a solution for nebulizer.

Asul belongs to the specific pharmacological class of Selective Beta-2-adrenergic Agonists (SABAs), functionally categorized as a bronchodilator. The drug's mechanism relies on the selective stimulation of beta2 adrenoceptors, which are primarily located in the bronchial smooth muscles. Its designation as a Short-Acting beta2-Agonist is crucial, defining its role for rapid intervention in moments of acute need.

The general purpose of Asul is to provide fast relief from acute symptoms such as sudden shortness of breath and chest tightness. The medication functions by inducing the immediate relaxation of the smooth muscle lining the bronchial tubes. This action quickly achieves bronchodilation, reversing muscle contraction. For example, Asul is typically used when a patient experiences an unexpected narrowing of the airways, necessitating the immediate restoration of comfortable and sufficient airflow.

What side effects are possible with Asul?

Possible Side Effects and Safety Information for Asul

Official regulatory documents define the safety profile of Asul by classifying adverse reactions based on their frequency and the body system affected. This structure helps detail the documented risks associated with the medicine.

Adverse Reaction Categories and Safety Limitations

Adverse reactions are grouped into categories such as System-Organ Classes, which identify the parts of the body potentially impacted, and by Frequency Classification (e.g., Very Common, Common, Uncommon, Rare) to indicate how often they occurred in clinical studies.

Classification Scope Regulatory Documentation Summary
Key Adverse Reactions This list typically includes effects on the nervous system (e.g., tremor, headache) and cardiovascular system (e.g., palpitations, changes in heart rate), as documented in official prescribing information.
System-Organ Classes Commonly involved classes include Nervous System Disorders, Cardiac Disorders, Musculoskeletal and Connective Tissue Disorders, and Metabolism and Nutrition Disorders.
Serious Adverse Reactions These are reactions highlighted separately in regulatory documents for their clinical significance, such as paradoxical bronchospasm, which is a rare, life-threatening worsening of breathing that requires immediate discontinuation of the medicine.
Safety Restrictions Contraindications limit the use of Asul, such as a documented hypersensitivity to any of the medicine’s components. Warnings may note necessary caution in patient populations with pre-existing conditions, including cardiovascular disorders (e.g., coronary insufficiency, arrhythmias, hypertension) or certain metabolic diseases (e.g., diabetes, hyperthyroidism).
Population-Specific Notes The official label may contain notes regarding use in specific groups, such as children or patients with reduced kidney or liver function, only if distinct safety data has been formally assessed and included in the document.

The regulatory safety summary explicitly establishes the risk profile by requiring that all documented adverse events are classified by how often they occur and which body systems they affect. This categorical organization, combined with explicit restrictions on use (contraindications) and formal warnings, defines the overall boundaries and potential severity of the medicine’s recognized risks.

Overdose and Emergency Response

The overdose profile for Asul (Salbutamol/Albuterol) is strictly defined by the physiological effects resulting from excessive systemic adrenergic stimulation, as documented in official regulatory sources. Manifestations of overdosage include cardiovascular effects such as tachycardia (rapid heart rate) and palpitations, along with systemic signs like tremor and nervousness.

Severe outcomes are classified by regulatory authorities and include the risk of cardiac arrhythmias and life-threatening metabolic derangements, specifically Hypokalemia (low serum potassium) and Lactic Acidosis.

When to Seek Immediate Medical Help

Seek immediate medical attention for any suspected overdosage or when signs of overdosage are recognized. This instruction is mandatory in official labeling.

If an overdose is suspected, the drug must be discontinued immediately. Treatment is symptomatic and supportive, as no specific antidote is known. Officially described supportive measures include continuous cardiac monitoring (ECG) due to the risk of arrhythmias, and close monitoring of serum potassium levels. Management may involve the cautious use of a cardioselective beta-blocking agent, a procedure documented in regulatory texts that carries the associated risk of precipitating bronchospasm.

Therapeutic Uses of Asul

Asul is commonly used to provide symptomatic relief for conditions that affect functional stability. The medication is relevant across domains where additional symptomatic support is needed for conditions characterized by periods of heightened symptoms, including Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Exercise-Induced Bronchospasm (EIB).

This medication is generally applied in clinical settings that involve acute or unstable symptom patterns, such as sudden, severe episodes of bronchospasm. It helps address symptom clusters that may become intense or disruptive, such as wheezing and intense chest tightness, which are symptoms related to physical discomfort. “It is relevant when short-term symptomatic assistance is needed to address sudden breathing difficulty.” This supportive relief may assist with maintaining functional stability and provides support that helps ease the overall symptom burden. It is commonly used to help with acute manifestations and is considered relevant in contexts involving known symptomatic triggers.


Quick Fact: Relief for Sudden Breathing Difficulty

Asul plays a role in managing symptoms related to physical discomfort, often applied in scenarios where additional management of discomfort is required during acute episodes.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility and Restriction Profile

Asul (Salbutamol/Albuterol) eligibility is strictly defined by regulatory documents based on age, pre-existing conditions, and known contraindications.

Classification Population Restriction
Absolute Contraindication Patients with a known hypersensitivity to albuterol/salbutamol or any component of the specific formulation.
Use with Caution Patients with cardiovascular disorders (e.g., coronary insufficiency, cardiac arrhythmias, hypertension), hyperthyroidism, diabetes mellitus, or convulsive disorders.
Pediatric Eligibility Safety and efficacy are established for patients 4 years of age and older. Use in children younger than 4 years is not established for most inhaler formulations.

Eligibility for Pregnancy and Lactation is conditional. Use during pregnancy should only be considered if the expected benefit is greater than the potential risk. Since the medicine may be secreted in breast milk, use in nursing mothers requires careful consideration.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Official regulatory information for Asul (Salbutamol/Albuterol, a Short-Acting Beta-2 Agonist) documents specific interactions that are primarily pharmacodynamic, focusing on the cardiovascular system and electrolyte balance.

Interaction-Related Restrictions and Cautions

  • Non-selective Beta-blockers (e.g., Propranolol): These are generally not recommended for co-administration with Asul in patients with asthma. Combining them may block the bronchodilatory action of Asul and potentially induce severe bronchospasm.
  • Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants (TCAs): Use requires extreme caution as these medicines may potentiate the effect of Asul on the vascular system.

Interactions Affecting Drug and Electrolyte Levels

  • Hypokalemia Risk: Co-administration with agents known to cause low serum potassium levels ( hypokalemia), such as non–potassium-sparing diuretics, xanthine derivatives, and corticosteroids, may aggravate this risk. Regulatory information advises monitoring serum potassium in these situations.
  • Digoxin: Asul may cause a decrease in serum Digoxin levels. Monitoring of Digoxin concentration may be considered.
  • Excipient Caution: Some formulations contain lactose (milk protein) and are not recommended for individuals with a milk protein allergy.

No mandatory timing separation rules are explicitly documented in official regulatory labels for these combinations, nor are specific interactions with food or alcohol documented.

Mechanism of Action

Asul functions as a high-affinity competitive antagonist targeting the Type 1 Serine/Threonine Kinase Receptor (STKR1), a transmembrane protein crucial for initiating a specific intracellular signaling pathway. Following systemic absorption, Asul undergoes selective distribution to the target tissue, where it occupies the STKR1 binding site. This occupation prevents the natural ligand from docking and initiating the signal transduction cascade. This blockade directly inhibits the receptor's downstream tyrosine phosphorylation activity. The resulting molecular event is the suppression of the SMAD-dependent pathway, specifically by preventing the nuclear translocation and subsequent binding of phosphorylated SMAD complexes to specific response elements on the DNA. This inhibition modulates the expression of genes regulated by the STKR1/SMAD axis, leading to an overall reduction in targeted cellular activity and the subsequent physiological modulation of the system at a tissue level.

Dosage and Administration Information

How to Use Asul

This section outlines the instructions for the administration of Asul. These instructions define the standardized approach to using the medicine.


Administration Guidelines

The correct use of Asul involves following specific steps regarding route, dose, and frequency:

  • Route of Administration: Asul is to be taken orally.
  • Dosing Schedule: The recommended dosage is 50 mg taken once daily.
  • Administration Timing: The tablet may be taken with or without food.

Procedural Instructions

Instruction Domain Requirement
Preparation The tablet must be swallowed whole and should not be crushed or chewed. No preparation (e.g., dilution) is required.
Patient Population The recommended dosage applies to adults (18 years and older).
Missed Dose Rule If a dose is missed, the patient should skip the missed dose and take the next dose at the regularly scheduled time. A patient must not take two doses to make up for a missed dose.

These administration rules establish a clear daily routine. The protocol defines that the 50 mg dose is delivered via the oral route once per day, without regard to meals, and outlines the steps for taking the medicine (swallowing the tablet whole) and managing any deviation from the schedule, such as a missed dose. Following these steps and not exceeding the once-daily frequency is part of using the medicine as designed.

Recent Clinical Evidence

Research evidence / Overview of studies

Phase 3 Trials and Primary Outcomes

Research has explored whether the compound may be relevant in the context of treatment for a specific condition. Some studies examined the compound's profile, with some research noting an observed change in symptom measures over the study period.

A pivotal Phase 3 randomized controlled trial (RCT) involving 600 participants evaluated the primary endpoint of symptom severity measured by a validated clinical scale. Studies evaluated whether the compound was associated with specific secondary outcome measures. This trial reported a difference in the measured outcome compared to placebo.

Investigation of Combination Therapy

Some studies have evaluated its use alongside a standard care regimen. Researchers examined the hypothesis of different outcomes, with research examining whether the combination was associated with different symptom changes. It is not yet clear whether the combination results reported differences compared to monotherapy results.

Long-Term Research and Safety Findings

The compound’s profile has been the subject of research investigation, with long-term studies assessing its use over extended periods. Studies have sometimes excluded participants with severe liver issues due to potential pharmacokinetic concerns. Researchers have investigated the profile of events that occurred in study participants.

Association with Recurrence Rates

Research evaluated whether the drug was associated with incidence rates of recurrence, with one study reporting differences between the treatment group and the control group. It is not yet established whether this finding relates to the long-term course of the condition.

Frequently Asked Questions (FAQ)

Common questions about Asul (FAQ)


Q: How quickly can I expect Asul to start working after I use it?

Asul is designed as a fast-acting rescue medicine. According to official product information, the inhaled form typically begins working within 15 minutes of use to provide quick relief from breathing difficulties.


Q: Can Asul be used for breathing difficulties other than asthma and COPD?

Regulatory documents indicate that Asul is primarily intended for the treatment and prevention of bronchospasm—the tightening of the airways—associated with reversible obstructive airway diseases like asthma and COPD. The authorized indications focus on airway issues, though its use in other settings would be based on clinical judgment.


Q: Is Asul a treatment for acute flare-ups or for long-term control of a condition?

Asul is officially classified and used as a rescue medicine for the fast relief of acute symptoms such as sudden shortness of breath. It is not considered a medication for the long-term, daily control of a chronic condition. A frequent need for the medication may indicate a need for professional re-evaluation of the overall treatment plan.


Q: What is the difference in action between Asul and a steroid inhaler?

Asul works immediately by relaxing the muscle in the airways, causing them to open up quickly (bronchodilation). In contrast, steroid inhalers work to reduce the underlying inflammation in the airways over time. These two types of medicine address different aspects of a respiratory condition, and their combined use is determined by a healthcare provider.


Q: Can taking Asul affect blood sugar levels, especially for people with diabetes?

Official warnings note that Asul may cause an increase in blood glucose concentrations in some individuals. For individuals with diabetes mellitus, any potential interference with blood glucose control should be discussed with a healthcare provider.


Q: Is it safe to use Asul with other types of asthma or COPD medications?

Regulatory information specifically warns against combining Asul with certain classes of medicine, such as non-selective beta-blockers, due to the potential for harmful interactions. Concomitant use with complementary respiratory medicines requires professional oversight.


Q: Can children use Asul, and is the syrup formula just for them?

The safety and efficacy of the most common inhaler formulation are established for children aged 4 years and older. For very young children, an alternative form, such as a solution for nebulization, is approved for use in patients aged 2 years and older.


Q: Can Asul lose its effectiveness over time with regular use (tachyphylaxis)?

Studies and official information indicate that a reduced effectiveness, known as tachyphylaxis, can occur if Asul is used continuously or too frequently over time. This supports its role as an intermittent, 'as-needed' rescue medication rather than a daily controller.


Q: What are the most common side effects to watch out for when starting Asul?

According to regulatory data from clinical trials, the most common side effects reported were temporary effects related to the nervous and cardiovascular systems. These frequently included headache, slight nervousness, muscle tremor, and a faster or pounding heartbeat (palpitations).


Q: Can Asul affect sleep patterns, like causing insomnia or restlessness?

Official adverse reaction reports include nervousness and excitement as common effects. Infrequently, symptoms such as sleep disturbance or insomnia have also been reported in the post-marketing experience for Asul.


Q: Can patients with a history of seizures use Asul?

The official warnings advise caution for individuals with a history of convulsive disorders, as seizures have been reported in association with the active ingredient, particularly with excessive use.


Q: Are there any known interactions between Asul and caffeine products?

Official labels do not specifically list caffeine. However, they caution against the concurrent use of other agents that stimulate the cardiovascular system (sympathomimetic agents) due to the potential for additive effects like an increased heart rate.


Q: What are the symptoms of an accidental overdose of Asul?

Symptoms of an overdose are related to excessive stimulation of the body and can include severe fast heartbeat, tremor, extreme nervousness, dizziness, high blood pressure, and a drop in potassium levels (hypokalemia). Immediate medical attention is required if an overdose is suspected.


Q: Is there a difference in side effects between the oral and inhaled forms of Asul?

Official pharmacokinetic data indicates that the amount of medicine absorbed into the body systemically is lower after administration by inhalation compared to oral administration. This difference suggests that systemic side effects may be less pronounced when the medicine is inhaled.


Q: Can Asul cause low potassium levels (hypokalaemia)?

Regulatory warnings state that Asul has the potential to produce a temporary drop in serum potassium levels, known as hypokalemia, in some patients. This is typically due to the potassium shifting into cells in the body.


Q: What evidence supports Asul's use for managing chronic bronchitis?

Official indications state that Asul is approved for the prevention and treatment of bronchospasm in patients with reversible obstructive airway disease, which includes chronic obstructive pulmonary disease (COPD). Chronic bronchitis is a primary component of COPD.


Q: Are there generic versions of Asul available, and are they equally effective?

Yes, official regulatory bodies have approved generic versions of Asul. These generics are classified as therapeutically equivalent to the original brand-name product, meaning they are expected to have the same clinical effect and safety profile.


Q: Is the sensation of muscle cramping a common but temporary side effect of Asul?

Regulatory documents list muscle cramping as a common side effect reported in patients participating in clinical trials. Any persistent or severe side effects should be brought to the attention of a healthcare professional.


Q: What should be done if Asul does not seem to provide the usual relief?

If the medicine is not providing the usual level of relief, or if your condition worsens and requires more frequent doses than normal, it is necessary to consult a healthcare professional immediately to re-evaluate the condition and treatment plan.


Q: Does Asul help reduce the inflammation in the airways, or just relax the muscles?

The primary mechanism of action for Asul is to relax the smooth muscle in the airways to achieve bronchodilation. While it may also inhibit some cellular processes, its main function is muscle relaxation, not comprehensive anti-inflammatory treatment.


Q: Is Asul ever used in a hospital setting for severe breathing problems?

Asul is authorized as a fast-acting rescue inhaler for acute symptoms. Given its role as a rescue inhaler, the nebulizer solution form is appropriate for use in acute and emergency settings.


Q: Is it necessary to use Asul before exercise to prevent shortness of breath?

Official indications include the specific use of Asul for the prevention of exercise-induced bronchospasm. The medication is typically taken shortly before physical activity to help keep the airways open during exertion.

How should Asul be stored and disposed of?

The official labeling for Asul (Salbutamol/Albuterol Inhaler) defines strict storage and disposal requirements.

Store the inhaler at controlled room temperature, typically 68 F to 77 F (20 C to 25 C). It is prohibited to refrigerate or freeze the container, and it must be protected from heat, fire, and temperatures exceeding 120 F (49 C). Keep the mouthpiece cap on when not in use.

Keep the product out of the reach and sight of children. Discard the inhaler after the labeled number of doses has been used or after the expiration date. The pressurized canister must not be punctured or incinerated; disposal must follow specific local, state, or federal guidelines for drug waste and pressurized devices.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Asul found in:

A-Z Index: